Biotie's Annual Financial Report and Corporate Governance Statement 2010 published
(Thomson Reuters ONE) -
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 25 March 2011 at 9.10 a.m.
Biotie's Annual Financial Report and Corporate Governance Statement 2010
published
Biotie Therapies Corp.' s Annual financial report for the financial period
ended 31 December 2010 as well as Corporate Governance Statement 2010 have been
published.
The documents are attached in pdf format in this release. Both documents are
also available at Biotie's website www.biotie.com in English and Finnish
language.
Turku, 25 March 2011
Biotie Therapies Corp.
Timo Veromaa
President and CEO
For further information, please contact:
Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail:virve.nurmi(at)biotie.com
DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com
Biotie Therapies Corp.
Biotie is a specialized drug development company focused on the development of
drugs for neurodegenerative and psychiatric disorders (e.g. Parkinson's disease,
Alzheimer's disease and other cognitive disorders, bipolar disorder, addictions
and drug dependence) and inflammatory diseases (rheumatoid arthritis, psoriasis,
chronic obstructive pulmonary disease and others).
It has several innovative small molecule and biological drug candidates at
different stages of clinical development. Biotie's products address diseases
with high unmet medical need and significant market potential.
Some of the programmes have been validated through licensing agreements for
development and commercialization with top-tier pharmaceutical partners
including H. Lundbeck A/S, UCB Pharma S.A.and Seikagaku Corporation. The most
advanced product, nalmefene for alcohol dependence, is currently in phase III
clinical development by licensing partner H. Lundbeck A/S.
Shares are listed on NASDAQ OMX Helsinki Ltd.
Biotie_Corporate Governance Statement 2010:
http://hugin.info/132030/R/1499904/435365.pdf
Biotie_Financial Statements 2010:
http://hugin.info/132030/R/1499904/435364.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biotie Therapies Oyj via Thomson Reuters ONE
[HUG#1499904]
Unternehmensinformation / Kurzprofil:
Datum: 25.03.2011 - 08:10 Uhr
Sprache: Deutsch
News-ID 52800
Anzahl Zeichen: 2892
contact information:
Town:
Turku
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 186 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Biotie's Annual Financial Report and Corporate Governance Statement 2010 published"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotie Therapies Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
